Paper Details 
Original Abstract of the Article :
Cardiorespiratory effects of an IV administered bolus of ketamine (7.5 mg/kg of body weight) and midazolam (0.375 mg/kg) followed by IV infusion of ketamine (200 micrograms/kg/min) and midazolam (10 micrograms/kg/min) for 60 minutes was determined in 6 dogs. Ketamine-midazolam combination was admini...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://pubmed.ncbi.nlm.nih.gov/8017701

データ提供:米国国立医学図書館(NLM)

Ketamine-Midazolam Anesthesia: A Camel's Perspective on Cardiorespiratory Effects

Ketamine and midazolam are commonly used anesthetic agents, but their effects on the cardiorespiratory system can vary. This study investigates the cardiorespiratory effects of an intravenous (IV) administration of a ketamine-midazolam combination, both with and without prior opioid administration. The authors conducted a controlled study in dogs, carefully monitoring cardiorespiratory variables to understand the impact of different drug combinations. Their findings revealed significant changes in cardiorespiratory parameters, particularly in response to opioid administration.

Opioid Administration: A Potential Impact on Anesthesia

This study provides valuable insights into the potential impact of opioid administration on the cardiorespiratory effects of ketamine-midazolam anesthesia. The authors' findings highlight the importance of carefully considering the potential interactions between different anesthetic agents. This research can inform clinicians in their efforts to optimize anesthetic regimens and ensure patient safety during surgical procedures.

Anesthesia: A Carefully Choreographed Journey

Anesthesia is a complex process, involving careful consideration of drug combinations and individual patient factors. This study provides valuable insights into the potential impact of opioid administration on cardiorespiratory function during ketamine-midazolam anesthesia. It's crucial to consult with a healthcare professional to discuss the most suitable anesthetic approach for your individual needs.

Dr.Camel's Conclusion

The field of anesthesia is a fascinating journey, filled with intricate pathways and potential pitfalls. This study provides valuable insights into the cardiorespiratory effects of ketamine-midazolam anesthesia, particularly in the context of opioid administration. By understanding these interactions, clinicians can work toward optimizing anesthetic regimens and ensuring the safety and well-being of their patients.

Date :
  1. Date Completed 1994-07-22
  2. Date Revised 2013-11-21
Further Info :

Pubmed ID

8017701

DOI: Digital Object Identifier

8017701

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.